APOC1 and diabetes mellitus: We can hypothesize that apoC1 may have different functions according to its distribution between lipoproteins (with a pro-atherogenic effect when associated with VLDL and an anti-atherogenic effect when associated with HDL) and that qualitative changes of apoC1 occurring in clinical situations as diabetes and atherosclerosis may also modify its properties and expression pattern.